Outsourced Pharma App Notes & Case Studies
-
Developing A HIC Polishing Step For The Removal Of mAb Aggregates
9/28/2023
Learn in-depth about the development of a flow-through polishing step that employs hydrophobic interaction chromatography for the elimination of monoclonal antibody aggregates.
-
Applying A Platform Approach To Bispecific Antibody Development
6/16/2023
Explore how experts were able to adjust a mAb production and purification platform to be applicable for the rapid development and scale up of a BsAb.
-
Scalability And Performance Of MobiusĀ® iFlex Bioreactors
1/19/2024
Utilizing single-use bioreactors in intensified fed-batch and perfusion processes can help manufacturers produce a high-quality drug supply while reducing facility footprint and production costs.
-
Peptide Mapping Of AAV By LC-MS
9/29/2022
View the results generated from an internal study where peptide mapping of two different AAV serotypes – AAV8 and AAV9 – was performed by LC-MS.
-
Meeting An Aggressive Go-To-Clinic Timeline
9/27/2023
Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.
-
TFF For Laboratory And Process Development Applications
3/1/2023
Learn about the basic principles that govern tangential flow filtration (TFF) along with the use of TFF capsules and cassettes in laboratory and process development applications.
-
Using Automated Spinoculation For CAR T Cell Lentiviral Transduction
2/26/2024
There is a growing demand for closed and automated lentiviral transduction steps in CAR T cell therapy workflows. Learn about a potential solution to address this unmet need.
-
AAV Production In Suspension HEK293 Cells With Single-Use Bioreactors
10/13/2022
Explore how we expanded HEK293/HEK293T suspension cells from small cell culture (20 mL) in shake flasks up to a 10 L culture in a benchtop Xcellerex™ XDR-10 single-use bioreactor system.
-
Reducing The Level Of Host Cell Proteins In The Bioreactor Harvest
10/20/2023
Learn how MilliporeSigma helped a customer drastically reduce the level of HCPs in the bioreactor harvest prior to a production run to supply drug substance for a scheduled Phase 1 clinical trial.
-
Understanding The Microfluidic Platforms For Scaling Nanoparticle Production
10/13/2022
Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.